Stock NDVA INDIVA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Indiva Limited

Equities

NDVA

CA45580J1012

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 03:31:12 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.07 CAD +16.67% Intraday chart for Indiva Limited +7.69% -26.32%
Mar. 04 Indiva Limited cancelled the transaction announced on February 28, 2024 CI
Feb. 28 Indiva Files Amended And Restated Offering Document And Announced Concurrent Private Placement Of Up To $4.3 Million MT

Business Summary

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

Sales per Business

CAD in Million2021Weight2022Weight Delta
Product
109.5 %
35 109.1 % 38 109.5 % +6.34%
Excise Taxes
-9.5 %
-3 -9.1 % -3 -9.5 % +10.55%

Sales per region

CAD in Million2021Weight2022Weight Delta
Canada
100.0 %
32 100.0 % 34 100.0 % +5.95%

Managers

Managers TitleAgeSince
Carmine Marotta FOU
 Founder - 79-09-12
Jennifer Ann Welsh DFI
 Director of Finance/CFO - 17-12-12
Robert William Carse COO
 Chief Operating Officer - 19-04-30
Anthony Simone IRC
 Investor Relations Contact - -
Alejandro Vernaza SAM
 Sales & Marketing - 18-02-28
Leslie Tomlenovich LAW
 General Counsel - 21-11-30
Sherry Kelly HRO
 Human Resources Officer - 18-07-31
Melissa Kurek PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Rachel Goldman BRD
 Director/Board Member 52 21-12-15
James Yersh BRD
 Director/Board Member - 17-12-12
Hugh Sutherland BRD
 Director/Board Member - 17-12-12
John Marotta BRD
 Director/Board Member - 17-12-12
Andre Lafleche BRD
 Director/Board Member - 17-12-12
Carmine Marotta FOU
 Founder - 79-09-12
Liam Wilson BRD
 Director/Board Member 33 21-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 195,488,563 124,545,610 ( 63.71 %) 0 63.71 %

Shareholders

NameEquities%Valuation
CANOPY GROWTH CORPORATION
19.30 %
35,948,500 19.30 % 2 M $
SNDL INC.
8.558 %
15,938,500 8.558 % 956 310 $
John Marotta
4.811 %
8,961,000 4.811 % 537 660 $
Andre Lafleche
2.729 %
5,082,702 2.729 % 304 962 $
Carmine Marotta
2.342 %
4,362,690 2.342 % 261 761 $
Sung Koo Kang
1.093 %
2,035,028 1.093 % 122 102 $
Hugh Sutherland
0.5071 %
944,444 0.5071 % 56 667 $
Liam Wilson
0.1532 %
285,277 0.1532 % 17 117 $
Jennifer Ann Welsh
0.1508 %
280,782 0.1508 % 16 847 $
James Yersh
0.1366 %
254,444 0.1366 % 15 267 $

Company contact information

Indiva Ltd.

333 Preston Street Suite 710

K1S 5N4, Ottawa

+888-649-6686

http://www.indiva.com
address Indiva Limited(NDVA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Ratings for Indiva Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.06 CAD
Average target price
0.12 CAD
Spread / Average Target
+100.00%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
INDIVA LIMITED Stock Indiva Limited
-26.32% 8.54M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+37.15% 6.12B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.04% 4.44B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-11.16% 3.14B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-1.40% 3.03B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
+0.12% 2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+38.69% 1.87B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.11% 1.63B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-10.34% 1.62B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. NDVA Stock
  4. Company Indiva Limited